| Literature DB >> 32490726 |
Aniello Maiese1, Giovanna Passaro2, Alessandra DE Matteis3, Valentina Fazio3, La Russa Raffaele3, Marco Di Paolo1.
Abstract
Viral sepsis is rare, and its real incidence is not known. SARS-CoV-2 infection causes the release of a significant amount of pro-inflammatory cytokines that aggravates interstitial pneumonia and evolves in viral sepsis with prominent hypercoagulability. We believe it is useful and advisable to establish early immunomodulator therapy and the prophylaxis anticoagulant therapy should be rethought.Entities:
Keywords: Sars-CoV-2; sepsis, COVID-19, Thrombosis, Coagulopathy
Mesh:
Substances:
Year: 2020 PMID: 32490726 DOI: 10.1177/0025817220926915
Source DB: PubMed Journal: Med Leg J ISSN: 0025-8172